Cambridge Investment Research Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 7,504 shares of JAZZ stock, worth $880,819. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,504
Previous 5,437
38.02%
Holding current value
$880,819
Previous $670,000
39.1%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding JAZZ
# of Institutions
588Shares Held
60.1MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$721 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$706 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$289 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$273 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$231 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.36B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...